Wells Fargo & Company Forecasts Strong Price Appreciation for Nutrien (NYSE:NTR) Stock

Nutrien (NYSE:NTRGet Free Report) had its price objective lifted by research analysts at Wells Fargo & Company from $64.00 to $77.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 8.16% from the stock’s previous close.

Other equities analysts also recently issued research reports about the stock. Barclays lifted their price target on shares of Nutrien from $64.00 to $70.00 and gave the company an “equal weight” rating in a report on Wednesday. Morgan Stanley raised shares of Nutrien from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $70.00 to $77.00 in a report on Wednesday, January 14th. Royal Bank Of Canada raised their price target on Nutrien from $70.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, January 20th. Mizuho boosted their price objective on Nutrien from $65.00 to $68.00 and gave the company a “neutral” rating in a research report on Friday, January 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Nutrien in a research report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $70.11.

View Our Latest Analysis on NTR

Nutrien Trading Down 0.8%

NYSE:NTR opened at $71.19 on Friday. Nutrien has a one year low of $45.78 and a one year high of $73.55. The business has a fifty day moving average price of $66.23 and a 200-day moving average price of $60.67. The firm has a market capitalization of $34.27 billion, a price-to-earnings ratio of 15.28 and a beta of 0.73. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.41 and a quick ratio of 0.89.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.46%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.31 EPS. Sell-side analysts forecast that Nutrien will post 3.72 EPS for the current year.

Hedge Funds Weigh In On Nutrien

Institutional investors have recently bought and sold shares of the business. Montag A & Associates Inc. raised its position in Nutrien by 310.7% in the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after purchasing an additional 320 shares during the period. Root Financial Partners LLC purchased a new stake in shares of Nutrien in the third quarter worth approximately $37,000. Sfam LLC purchased a new stake in shares of Nutrien in the fourth quarter worth approximately $37,000. Huntington National Bank lifted its stake in shares of Nutrien by 72.6% during the 2nd quarter. Huntington National Bank now owns 656 shares of the company’s stock worth $38,000 after acquiring an additional 276 shares during the last quarter. Finally, Eastern Bank boosted its holdings in Nutrien by 133.0% during the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares during the period. Institutional investors own 63.10% of the company’s stock.

Nutrien News Summary

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Multiple broker upgrades and higher price targets — BMO raised its target to $85 (outperform), JPMorgan to $78 (overweight), Wells Fargo to $77 (equal weight) and Raymond James to $74, signaling analyst confidence in Nutrien’s outlook and suggesting meaningful upside from recent levels. BayStreet.CA Benzinga
  • Positive Sentiment: Shareholder returns: Nutrien raised its quarterly dividend (to $0.55) and announced a new buyback program — a direct positive for investors seeking yield and capital return. TipRanks
  • Positive Sentiment: Favorable commodity outlook: Management expects stronger global potash demand in 2026 despite difficult farm economics — a revenue/volume tailwind for Nutrien’s fertilizer segment. Reuters
  • Neutral Sentiment: Earnings materials available — full Q4 2025 call transcript and presentation have been published for investor review; useful for drilling into segment-level detail but not a directional catalyst by itself. Seeking Alpha Yahoo Finance
  • Neutral Sentiment: Some analysts remain cautious: Bank of America raised its target to $71 but kept a neutral rating (minimal implied upside). That tempers the bullish momentum from higher targets. Benzinga
  • Negative Sentiment: Operational results missed consensus: Q4 EPS came in at $0.83 vs. $0.87 expected and revenue of ~$5.12B was slightly below estimates — the earnings miss is the primary near-term negative pressure on the share price. Zacks
  • Negative Sentiment: Mixed analyst views persist — UBS assigned a “hold,” which indicates some investors and brokers are reserving judgment despite the positive catalysts. Globe & Mail

About Nutrien

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Articles

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.